Abstract
Dexmedetomidine, a selective alpha 2-adrenoceptor (α2AR) agonist, has provided significant analgesia in neuropathic pain. However, its underlying molecular mechanism has not been fully elucidated. In the present study, we found that intrathecal administration of dexmedetomidine alleviated mechanical allodynia induced by chronic constriction injury (CCI), and pretreatment with BRL44408 significantly reversed the dexmedetomidine-induced anti-nociceptive effect. Western blotting revealed that dexmedetomidine reduced the activation of microglia and the upregulation of interleukin-18 (IL-18) protein expression in the ipsilateral lumbar spinal dorsal horn, while BRL44408 pretreatment significantly blocked these effects of dexmedetomidine. Immunocytochemistry/immunohistochemistry indicated that the α2A-adrenoceptor was localised to microglia in primary culture, and IL-18 predominantly colocalised with the microglial marker Iba-1 in the dorsal horn of the spinal cord. These results suggest that the IL-18 signalling pathway in microglia may be involved in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI.
References
Apr 1, 1988·Pain·G J Bennett, Y K Xie
Jul 31, 2001·Trends in Neurosciences·L R WatkinsS F Maier
Nov 9, 2002·Neuropharmacology·Kohji MoriJunya Tanaka
Dec 5, 2003·Nature Reviews. Drug Discovery·Linda R Watkins, Steven F Maier
Jan 26, 2005·Trends in Neurosciences·Makoto TsudaMichael W Salter
Apr 20, 2005·Pain·Annemarie LedeboerLinda R Watkins
Mar 15, 2006·Current Opinion in Anaesthesiology·Andrea Paris, Peter H Tonner
Apr 21, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bryan C Hains, Stephen G Waxman
Aug 26, 2006·Anesthesia and Analgesia·Jijun J XuHoward B Gutstein
Nov 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kan MiyoshiKoichi Noguchi
Apr 7, 2010·Acta Pharmacologica Sinica·Bo XuYu-qiu Zhang
Jul 16, 2010·Clinical and Experimental Pharmacology & Physiology·Bo XuYu-Qiu Zhang
Jul 19, 2011·Pain·Troels S JensenRolf-Detlef Treede
Jan 12, 2012·Neuroscience Bulletin·Yu-Xia ChuZhi-Qi Zhao
Aug 25, 2012·Neuroscience Letters·Masafumi KimuraHideaki Obata
Feb 15, 2013·PloS One·Hongxing ZhangHong Ma
Citations
Mar 29, 2014·PloS One·Huang-Hui WuWen Wang
Jul 17, 2015·Acupuncture in Medicine : Journal of the British Medical Acupuncture Society·Yi LiangJianqiao Fang
May 20, 2015·Journal of Neuroinflammation·Paul J AustinKevin A Keay
Apr 17, 2016·Neurochemical Research·Prashanth KomirishettyAshutosh Kumar
Apr 16, 2015·ACS Chemical Neuroscience·Li-Wen ChuBin-Nan Wu
Apr 24, 2015·PloS One·Paul J AustinKevin A Keay
Apr 17, 2018·Pharmaceutical Biology·Agnieszka M JurgaJoanna Mika
Oct 16, 2014·The Korean Journal of Pain·Kyung Hoon Kim
May 20, 2018·Scientific Reports·Ling-Er HuangYong-Xing Yao
Jan 13, 2015·Anesthesiology·Christopher M PetersJames C Eisenach
Oct 5, 2019·Neurological Research·Yiling QianZhiping Wang
Dec 5, 2017·Experimental and Therapeutic Medicine·Dong JiHua Xu
Jun 20, 2017·Biological & Pharmaceutical Bulletin·Yuecheng LuJunmin Zhong
Sep 6, 2018·Experimental Neurobiology·Jia-Piao LinYong-Xing Yao
Sep 18, 2018·International Journal of Molecular Medicine·Wanmin PeiLi Li
Feb 1, 2021·Neuropharmacology·Fabiolla Rocha Santos PassosJullyana S S Quintans
Oct 31, 2021·Molecular Psychiatry·Alan ProssinJon-Kar Zubieta